Medicines

Spain: 69 adverse reactions per 100,000 doses of COVID vaccines

In Spain, 55,455 cases of adverse reactions to vaccines against COVID-19 have been reported after the administration of 80 million doses, which corresponds to 69 notifications per 100,000 injected doses, 0.069%. ...

The EMA recommends the authorization of Paxlovid, Pfizer’s antiviral

The European Medicines Agency (EMA) recommends conditional marketing authorization for Paxlovid, Pfizer's antiviral drug pills, 89% effective against hospitalizations and deaths from severe COVID. The...

COVID vaccine could affect menstruation, but not fertility

Vaccines against COVID-19 may slightly and temporarily alter the menstrual cycle, but do not affect pregnancy rates in women undergoing in vitro fertilization (IVF), new studies confirm. ...

COVID vaccines reduce the risk of death by 100 times in those infected

People with the complete COVID-19 vaccination schedule who become infected with the coronavirus have up to 41 times less risk of being hospitalized, 154 times less risk of being admitted to...

First human trials of Moderna’s mRNA HIV vaccine

A new Moderna HIV vaccine based on the messenger RNA technique – the same one used in its COVID-19 vaccine – is going to begin testing in humans, the biotechnology company...

Intranasal vaccine with nanoparticles effective against influenza

An experimental nasal flu vaccine containing nanoparticles with adjuvants and antigens is capable of improving the immune response and its duration, a trial in mice shows. ...

The phase III clinical trial of the Spanish COVID vaccine is approved

The vaccine developed by the biotech pharmaceutical company Hipra has received authorization from the AEMPS to begin its phase III clinical trial, where its safety and efficacy as a booster dose...

Drugs identified that could reduce mortality from COVID-19

A series of drugs with immunosuppressive capacity could reduce the cytokine storm that is triggered in some patients with severe COVID-19, which could help reduce the risk of death. ...

They create nanocapsules with microRNA that could help treat cancer

A group of CSIC researchers has designed injectable microRNA nanocapsules that are capable of interrupting the spread of tumor cells in cancers such as lung, liver or neuroblastomas. ...

New combination of antivirals very effective against coronavirus

They identify a powerful combination of antiviral drugs to treat COVID-19 that have proven effective in inhibiting SARS-CoV-2. The therapy is based on combining the drug brequinar with remdesivir or...

Insulin-regulating drugs could help treat autism

Drug-deletion of the Neurexin1 gene, which reduces glucose metabolism in the brain's prefrontal cortex, could be an effective therapeutic strategy for neurodevelopmental disorders such as autism. ...

Pegcetacoplan can delay the onset of macular degeneration

Administering the drug pegcetacoplan to people with a predisposition to developing age-related macular degeneration (AMD) can delay its onset in some cases, a clinical trial shows. ...

Okedi, new drug to treat schizophrenia authorized by the EC

The European Commission approves the marketing of the injectable antipsychotic drug Okedi (Risperidone ISM®) for the treatment of schizophrenia after verifying its safety and efficacy in adult patients. ...

What to take to reduce nausea

Nausea is the feeling of having to vomit. There are several medications available to treat them, including antiemetics and antihistamines. Certain foods or changing dietary habits can also help relieve them. Nausea...

Povidone-iodine, what it is for and when it is used

Povidone-iodine is one of the basic products in the medicine cabinet to heal and disinfect wounds, however, there is controversy about its use. Find out what Betadine is, when it...

Cannabidiol fever: properties, uses and risks of CBD

Cannabidiol (CBD) is a non-psychotropic component of cannabis that has some health benefits, from analgesic or anticonvulsant to anxiety control. We analyze the reason for its boom, its uses and...